All Stories

  1. A mobile phone application for the prevention of type 2 diabetes in Malaysian women with gestational diabetes mellitus ( MYGODDESS ): A feasibility randomised controlled trial
  2. The anxiolytic effects of quetiapine and lithium and anxiety as a moderator of the antidepressant effect: a secondary analysis of the lithium versus quetiapine in depression (LQD)trial
  3. The Syndemic Effects of Food Insecurity, Depression, and Gender-Based Violence on HIV Treatment Outcomes Among People with HIV in Zimbabwe
  4. Barriers and facilitators to diabetes prevention support for women in Malaysia with gestational diabetes mellitus: A qualitative study
  5. Prevalence of sleep disturbances and its associated factors in patients with generalised anxiety disorder: A systematic review and meta-analysis
  6. Clinical and cost-effectiveness of lithium versus quetiapine augmentation for treatment-resistant depression in adults: LQD a pragmatic randomised controlled trial
  7. African Youth in Mind – Protocol of a Pilot feasibility trial of a brief psychological Intervention for older adolescents with depression delivered through senior high schools in Navrongo, Ghana
  8. Clinical and cost-effectiveness of lithium versus quetiapine augmentation for treatment-resistant depression: a pragmatic, open-label, parallel-group, randomised controlled superiority trial in the UK
  9. Shortening duration of untreated illness in young people with first episode eating disorders: protocol of a randomised controlled feasibility trial of a smartphone friendly multi-modal decision-making tool (FREED-M) to improve help-seeking
  10. Early‐stage randomised controlled trial of therapist‐supported online cognitive therapy for post‐traumatic stress disorder in young people
  11. Process Evaluations of Interventions for the Prevention of Type 2 Diabetes in Women With Gestational Diabetes Mellitus: Systematic Review
  12. Supporting African communities to increase resilience and mental health of kids with developmental disabilities and their caregivers using the World Health Organization’s Caregiver Skills Training Programme (SPARK trial): study protocol for a cluster r...
  13. RELAX (REducing Levels of AnXiety): a study protocol for a parallel two-arm randomised controlled trial evaluating a web-based early intervention for pregnant women with high levels of repetitive negative thinking to prevent escalating anxiety during p...
  14. Moderators of the Effects of a Digital Parenting Intervention on Child Conduct and Emotional Problems Implemented During the COVID-19 Pandemic: Results From a Secondary Analysis of Data From the Supporting Parents and Kids Through Lockdown Experiences ...
  15. Neural responses to facial emotions and subsequent clinical outcomes in difficult-to-treat depression
  16. The Role of Subgenual Resting-State Connectivity Networks in Predicting Prognosis in Major Depressive Disorder
  17. Cost‐effectiveness of a Novel Hypoglycaemia Programme: The ‘HARPdoc vs BGAT’ RCT
  18. Neural signatures of emotional biases predict clinical outcomes in difficult-to-treat depression
  19. Cognitive Remediation in Bipolar (CRiB2): study protocol for a randomised controlled trial assessing efficacy and mechanisms of cognitive remediation therapy compared to treatment as usual
  20. Management of fraudulent participants in online research: Practical recommendations from a randomized controlled feasibility trial
  21. Toward an integrated approach for mental health and psychosocial support and peacebuilding in North-East Nigeria: programme description and preliminary outcomes from ‘Counselling on Wheels’
  22. Mechanisms of improved body composition among perimenopausal women practicing Meditative Movement: a proposed biobehavioral model
  23. Remote Recruitment Strategy and Structured E-Parenting Support (STEPS) App: Feasibility and Usability Study
  24. The Effectiveness and Cost-Effectiveness of a Universal Digital Parenting Intervention Designed and Implemented During the COVID-19 Pandemic: Evidence From a Rapid-Implementation Randomized Controlled Trial Within a Cohort
  25. Antidepressant Advisor (ADeSS): a decision support system for antidepressant treatment for depression in UK primary care – a feasibility study
  26. Factors associated with anxiety disorder comorbidity
  27. Well-being predictors of body composition and associated behavioral risk factors in midlife/older women participating in a meditative movement intervention: an exploratory analysis
  28. Self-blame-selective hyper-connectivity between anterior temporal and subgenual cortices predicts prognosis in major depressive disorder
  29. Trajectories of depression and anxiety symptom severity during psychological therapy for common mental health problems
  30. Online Parent Training for The Initial Management of ADHD referrals (OPTIMA): the protocol for a randomised controlled trial of a digital parenting intervention implemented to support parents and children on a treatment waitlist
  31. The cost-effectiveness of financial incentives to achieve heroin abstinence in individuals with heroin use disorder starting new treatment episodes: A cluster randomised controlled trial-based economic evaluation
  32. Transdiagnostic therapy for persistent physical symptoms: A mediation analysis of the PRINCE secondary trial
  33. Task-sharing with lay counsellors to deliver a stepped care intervention to improve depression, antiretroviral therapy adherence and viral suppression in people living with HIV: a study protocol for the TENDAI randomised controlled trial
  34. A Mobile Phone App for the Prevention of Type 2 Diabetes in Malaysian Women With Gestational Diabetes Mellitus: Protocol for a Feasibility Randomized Controlled Trial
  35. A systematic literature review of randomized controlled trials evaluating prognosis following treatment for adults with chronic fatigue syndrome
  36. A parallel randomised controlled trial of the Hypoglycaemia Awareness Restoration Programme for adults with type 1 diabetes and problematic hypoglycaemia despite optimised self-care (HARPdoc)
  37. Childhood gender-typed behaviour, sexual orientation, childhood abuse and post-traumatic stress disorder: a prospective birth-cohort study
  38. Characteristics of adults with type 1 diabetes and treatment-resistant problematic hypoglycaemia: a baseline analysis from the HARPdoc RCT
  39. Therapist-supported online cognitive therapy for post-traumatic stress disorder (PTSD) in young people: protocol for an early-stage, parallel-group, randomised controlled study (OPTYC trial)
  40. A pilot economic evaluation of a feasibility trial for SUpporting wellbeing through PEeR-Befriending (SUPERB) for post-stroke aphasia
  41. The feasibility of a strategy for the remote recruitment, consenting and assessment of recent referrals: a protocol for phase 1 of the On-Line Parent Training for the Initial Management of ADHD referrals (OPTIMA)
  42. Comparison of symptom-based versus self-reported diagnostic measures of anxiety and depression disorders in the GLAD and COPING cohorts
  43. Pilot study of tai chi and qigong on body composition, sleep, and emotional eating in midlife/older women
  44. Self-blame in major depression: a randomised pilot trial comparing fMRI neurofeedback with self-guided psychological strategies
  45. Discernment of mediator and outcome measurement in the PACE trial
  46. A Guideline for Reporting Mediation Analyses of Randomized Trials and Observational Studies
  47. Protocol for a qualitative study exploring the perception of need, importance and acceptability of a digital diabetes prevention intervention for women with gestational diabetes mellitus during and after pregnancy in Malaysia (Explore-MYGODDESS)
  48. SUpporting wellbeing through PEeR-Befriending (SUPERB) feasibility trial: fidelity of peer-befriending for people with aphasia
  49. The Feasibility of a Strategy for the Remote Recruitment, Consenting and Assessment of Recent Referrals: A Protocol for Phase 1 of the on-line Parent Training for the Initial Management of ADHD Referrals (OPTIMA).
  50. Cost effectiveness of therapist delivered cognitive behavioural therapy and web-based self-management in irritable bowel syndrome: the ACTIB randomised trial
  51. Using a pragmatically adapted, low-cost contingency management intervention to promote heroin abstinence in individuals undergoing treatment for heroin use disorder in UK drug services (PRAISE): a cluster randomised trial
  52. Development and validation of the Maudsley Modified Patient Health Questionnaire (MM-PHQ-9)
  53. “Loneliness can also kill:” a qualitative exploration of outcomes and experiences of the SUPERB peer-befriending scheme for people with aphasia and their significant others
  54. “For them and for me”: a qualitative exploration of peer befrienders’ experiences supporting people with aphasia in the SUPERB feasibility trial
  55. Supporting Parents & Kids Through Lockdown Experiences (SPARKLE): A digital parenting support app implemented in an ongoing general population cohort study during the COVID-19 pandemic: A structured summary of a study protocol for a randomised cont...
  56. ‘Emotion is of the essence. … Number one priority’: A nested qualitative study exploring psychosocial adjustment to stroke and aphasia
  57. Association of Patient Mental Health Status With the Level of Agreement Between Patient and Physician Ratings of Psoriasis Severity
  58. Mediators of the Disparities in Depression Between Sexual Minority and Heterosexual Individuals: A Systematic Review
  59. Supporting wellbeing through peer-befriending (SUPERB) for people with aphasia: A feasibility randomised controlled trial
  60. Discernment of Mediator and Outcome Measurement in the PACE trial
  61. Cost Effectiveness of Therapist Delivered Cognitive Behavioural Therapy and Web-Based Self-Management in Irritable Bowel Syndrome: The ACTIB Randomised Trial
  62. Comparison of algorithm-based versus single-item phenotyping measures of depression and anxiety disorders in the GLAD Study cohort
  63. Mobile telephone delivered contingency management for encouraging adherence to supervised methadone consumption: feasibility study for an RCT of clinical and cost-effectiveness (TIES)
  64. A Protocol of Process Evaluations of Interventions for the Prevention of Type 2 Diabetes in Women With Gestational Diabetes Mellitus: A Systematic Review
  65. Patients’ Experiences of Telephone-Based and Web-Based Cognitive Behavioral Therapy for Irritable Bowel Syndrome: Longitudinal Qualitative Study
  66. A Protocol of Process Evaluation of Interventions for the Prevention of Type 2 Diabetes in Women with Gestational Diabetes Mellitus: A Systematic Review
  67. Psychosocial mediators of the relations between sexual orientation and depressive symptoms in a longitudinal sample of young people.
  68. How and for whom does supportive adjustment to multiple sclerosis cognitive-behavioural therapy work? A mediated moderation analysis
  69. Study protocol for the antidepressant advisor (ADeSS): a decision support system for antidepressant treatment for depression in UK primary care: a feasibility study
  70. Telephone delivered incentives for encouraging adherence to supervised methadone consumption (TIES): Study protocol for a feasibility study for an RCT of clinical and cost effectiveness
  71. The Genetic Links to Anxiety and Depression (GLAD) Study: Online recruitment into the largest recontactable study of depression and anxiety
  72. Cognitive behavioural therapy for irritable bowel syndrome: 24-month follow-up of participants in the ACTIB randomised trial
  73. Intervening against mental illness stigma and its internalisation: An organising framework
  74. The Genetic Links to Anxiety and Depression (GLAD) Study: online recruitment into the largest recontactable study of depression and anxiety
  75. Hypoglycaemia Awareness Restoration Programme for People with Type 1 Diabetes and Problematic Hypoglycaemia Persisting Despite Optimised Self-care (HARPdoc): protocol for a group randomised controlled trial of a novel intervention addressing cognitions
  76. A genome-wide association meta-analysis of prognostic outcomes following cognitive behavioural therapy in individuals with anxiety and depressive disorders
  77. Assessing telephone-delivered cognitive–behavioural therapy (CBT) and web-delivered CBT versus treatment as usual in irritable bowel syndrome (ACTIB): a multicentre randomised trial
  78. Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT
  79. Childhood gender‐typed behavior and emotional or peer problems: a prospective birth‐cohort study
  80. The PACE trial of treatments for chronic fatigue syndrome: a response to WILSHIRE et al
  81. How can we successfully recruit depressed people? Lessons learned in recruiting depressed participants to a multi-site trial of a brief depression intervention (the ‘CLASSIC’ trial)
  82. Adjustment with aphasia after stroke: study protocol for a pilot feasibility randomised controlled trial for SUpporting wellbeing through PEeR Befriending (SUPERB)
  83. Key mechanisms of cognitive behavioural therapy in irritable bowel syndrome: The importance of gastrointestinal related cognitions, behaviours and general anxiety
  84. Cognitive and Behavioral Differences Between Subtypes in Refractory Irritable Bowel Syndrome
  85. SUpporting well-being through PEeR-Befriending (SUPERB) trial: an exploration of fidelity in peer-befriending for people with aphasia
  86. Blinding participants and assessors in a feasibility randomised controlled trial of peer-befriending for people with aphasia post-stroke
  87. How can we figure out how treatments work?
  88. The importance of cluster analysis for enhancing clinical practice: an example from irritable bowel syndrome
  89. Psychometric properties and factor structure of a shortened version of the Cognitive Behavioural Responses Questionnaire (CBRQ)
  90. Study protocol for a randomised pragmatic trial comparing the clinical and cost effectiveness of lithium and quetiapine augmentation in treatment resistant depression (the LQD study)
  91. The journey between brain and gut: A systematic review of psychological mechanisms of treatment effect in irritable bowel syndrome
  92. Guided Self-Help for Patients with Chronic Fatigue Syndrome Prior to Starting Cognitive Behavioural Therapy: a Cohort Study
  93. Response to the editorial by Dr Geraghty
  94. Do more people recover from chronic fatigue syndrome with cognitive behaviour therapy or graded exercise therapy than with other treatments?
  95. The NOURISHED randomised controlled trial comparing mentalisation-based treatment for eating disorders (MBT-ED) with specialist supportive clinical management (SSCM-ED) for patients with eating disorders and symptoms of borderline personality disorder
  96. Measurement error, time lag, unmeasured confounding: Considerations for longitudinal estimation of the effect of a mediator in randomised clinical trials
  97. Cognitive behaviour therapy for chronic fatigue syndrome: Differences in treatment outcome between a tertiary treatment centre in the United Kingdom and the Netherlands
  98. Patient reaction to the PACE trial – Authors' reply
  99. Establishing how psychological therapies work: the importance of mediation analysis
  100. Rehabilitative treatments for chronic fatigue syndrome: long-term follow-up from the PACE trial
  101. Methods and outcome reporting in the PACE trial–Author's reply
  102. Rehabilitative therapies for chronic fatigue syndrome: a secondary mediation analysis of the PACE trial
  103. Adverse events and deterioration reported by participants in the PACE trial of therapies for chronic fatigue syndrome
  104. One-day cognitive-behavioural therapy self-confidence workshops for people with depression: randomised controlled trial
  105. PACE trial authors' reply to letter by Kindlon
  106. Letter to the Editor: Response to correspondence concerning ‘Recovery from chronic fatigue syndrome after treatments in the PACE trial’
  107. Recovery from chronic fatigue syndrome after treatments given in the PACE trial
  108. A randomised trial of adaptive pacing therapy, cognitive behaviour therapy, graded exercise, and specialist medical care for chronic fatigue syndrome (PACE): statistical analysis plan
  109. Adaptive Pacing, Cognitive Behaviour Therapy, Graded Exercise, and Specialist Medical Care for Chronic Fatigue Syndrome: A Cost-Effectiveness Analysis
  110. Prolonged Stay in Intensive Care Unit Is a Powerful Predictor of Adverse Outcomes After Cardiac Operations
  111. How do treatments for chronic fatigue syndrome work? Exploration of instrumental variable methods for mediation analysis in PACE – a randomised controlled trial of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and speci...
  112. Department of Error
  113. The PACE trial in chronic fatigue syndrome – Authors' reply
  114. Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial
  115. Collaborative community based care for people and their families living with schizophrenia in India: protocol for a randomised controlled trial
  116. Comparison of Outcomes From Smoking and Nonsmoking Donors: Thirteen-Year Experience
  117. Microsimulation and clinical outcomes analysis support a lower age threshold for use of biological valves
  118. A lipopolysaccharide adsorber in adult cardiopulmonary bypass: a single centre randomised controlled pilot trial
  119. A Valuation of Infusion Therapy to Preserve Islet Function in Type 1 Diabetes
  120. Mapping of the EQ-5D index from clinical outcome measures and demographic variables in patients with coronary heart disease
  121. A review of health utilities using the EQ-5D in studies of cardiovascular disease
  122. Aspiration and development of subglottic stenosis in patients with Wegener’s granulomatosis
  123. Connective Tissue Disease–associated Pulmonary Arterial Hypertension in the Modern Treatment Era
  124. Relationship between the EQ-5D index and measures of clinical outcomes in selected studies of cardiovascular interventions
  125. Life-Years Gained by Reducing Donor Heart Ischemic Times
  126. The influence of seasonal variation on cardiac surgery: A time-related clinical outcome predictor
  127. Prognostic and aetiological factors in chronic thromboembolic pulmonary hypertension
  128. Current differences in referral patterns for pulmonary endarterectomy in the UK
  129. Long-term Use of Sildenafil in Inoperable Chronic Thromboembolic Pulmonary Hypertension
  130. What affected survival of Papworth Hospital heart transplantation patients over the first 25 years?
  131. Impact of Cardiothoracic Resident Turnover on Mortality After Cardiac Surgery: A Dynamic Human Factor
  132. Clinical and cost-effectiveness analysis of an open label, single-centre, randomised trial of spinal cord stimulation (SCS) versus percutaneous myocardial laser revascularisation (PMR) in patients with refractory angina pectoris: The SPiRiT trial
  133. The Papworth BiVent tube: a new device for lung isolation
  134. Improved Outcomes in Medically and Surgically Treated Chronic Thromboembolic Pulmonary Hypertension
  135. Does perioperative use of aprotinin reduce the rejection rate in heart transplant recipients?☆
  136. Fibrinogen A  Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension
  137. Role of NT-proBNP and 6MWD in chronic thromboembolic pulmonary hypertension
  138. Reply to Yavuz et al.
  139. Unintended Childbearing and Knowledge of Emergency Contraception in a Population-Based Survey of Postpartum Women
  140. Unintended Childbearing and Knowledge of Emergency Contraception in a Population-Based Survey of Postpartum Women
  141. A surgeon's case volume of oesophagectomy for cancer strongly influences the operative mortality rate
  142. Report of the Specialist Advisory Committee on Antimicrobial Resistance (SACAR) Surveillance Subgroup
  143. Right Ventricular Septal Pacing
  144. Acute haemodynamic responses to inhaled nitric oxide and intravenous sildenafil in distal chronic thromboembolic pulmonary hypertension (CTEPH)
  145. Delayed re-exploration for bleeding after coronary artery bypass surgery results in adverse outcomes☆
  146. An Assessment of Web Accessibility Knowledge and Needs at Oregon Community Colleges
  147. The Extracellular Domain of Herpes Simplex Virus gE Is Indispensable for Efficient Cell-to-Cell Spread: Evidence for gE/gI Receptors
  148. Herpes Simplex Virus Glycoproteins gD and gE/gI Serve Essential but Redundant Functions during Acquisition of the Virion Envelope in the Cytoplasm
  149. Herpes Simplex Virus with Highly Reduced gD Levels Can Efficiently Enter and Spread between Human Keratinocytes
  150. Infected Cell Protein (ICP)47 Enhances Herpes Simplex Virus Neurovirulence by Blocking the CD8+T Cell Response